Compared to Estimates, CRH (CRH) Q2 Earnings: A Look at Key Metrics
Werte in diesem Artikel
CRH (CRH) reported $10.21 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 5.7%. EPS of $1.94 for the same period compares to $1.85 a year ago.The reported revenue represents a surprise of -1.19% over the Zacks Consensus Estimate of $10.33 billion. With the consensus EPS estimate being $1.84, the EPS surprise was +5.43%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how CRH performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Americas Materials Solutions: $4.51 billion versus the three-analyst average estimate of $4.7 billion.Revenue- International Solutions: $3.54 billion versus $3.44 billion estimated by three analysts on average.Revenue- Americas Building Solutions: $2.16 billion versus the three-analyst average estimate of $2.17 billion.View all Key Company Metrics for CRH here>>>Shares of CRH have returned +3.5% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CRH PLC (CRH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf CRH
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CRH
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu CRH plc
Analysen zu CRH plc
Datum | Rating | Analyst | |
---|---|---|---|
06.10.2023 | CRH Buy | Jefferies & Company Inc. | |
27.09.2023 | CRH Buy | Jefferies & Company Inc. | |
26.09.2023 | CRH Buy | UBS AG | |
13.09.2023 | CRH Overweight | JP Morgan Chase & Co. | |
12.09.2023 | CRH Buy | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
06.10.2023 | CRH Buy | Jefferies & Company Inc. | |
27.09.2023 | CRH Buy | Jefferies & Company Inc. | |
26.09.2023 | CRH Buy | UBS AG | |
13.09.2023 | CRH Overweight | JP Morgan Chase & Co. | |
12.09.2023 | CRH Buy | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
13.07.2022 | CRH Equal-weight | Morgan Stanley | |
15.03.2022 | CRH Equal-weight | Morgan Stanley | |
04.03.2022 | CRH Equal Weight | Barclays Capital | |
19.01.2022 | CRH Equal Weight | Barclays Capital | |
17.12.2021 | CRH Hold | Kepler Cheuvreux |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CRH plc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen